CIK 0001513525
- Non-accelerated filer
- Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800667150
- Phone
- +1 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- 4 Open-market buy Chief Medical Officer bought 73,100 shares at an average $3.29 ($240,609)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Financial Officer acquired 5,927 shares (conversion)
- 4 Open-market buy Chief Executive Officer bought 80,000 shares
- 4 Open-market buy Director bought 90,000 shares
- 4 Open-market buy Director bought 20,000 shares
- 4 Open-market buy Director bought 1,400 shares
- 4 Open-market buy Director bought 7,000 shares
- 4 Open-market buy Director bought 14,000 shares
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 7 · 123 filings